Colin Sandercock insider trades

Open-market stock purchases and sales by Colin Sandercock, SVP, GENERAL COUNSEL at Cue Biopharma, Inc, from SEC Form 4 filings since Dec 27, 2017.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +273%.

Recent trades

DateStockTradeValue
Apr 9, 2026CUE Cue Biopharma, IncBought (not open market)—
Dec 3, 2025CUE Cue Biopharma, IncBought (not open market)—

Companies traded

  • CUE Cue Biopharma, Inc: 4 buys, 4 sales, last Apr 9, 2026

Get free alerts when Colin Sandercock files a new trade →